Everolimus granted European Licence for renal AML
Everolimus granted European Licence for renal AML Everolimus (trade name Votubia®) has been approved by the regulators for use in the European Union for the treatment of angiomyolipomata (AMLs) in adults with TSC, when embolisation or surgery is not immediately needed. Everolimus belongs to a